Results 151 to 160 of about 299,280 (207)

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors. [PDF]

Int J Mol Sci
Climent E, González-Guerrero A, Marco-Benedí V, García-Andreu MD, Mediavilla-García JD, Suárez-Tembra M, Benaiges D, Pintó X, Pedro-Botet J.   +8 more
europepmc   +1 more source

Adherence to the Healthy Nordic Food Index is associated with reduced plasma levels of inflammatory markers in patients with heterozygous familial hypercholesterolemia. [PDF]

Atheroscler Plus
Løvheim EB, Retterstøl K, Narverud I, Bogsrud MP, Halvorsen B, Ueland T, Aukrust P, Holven KB.   +7 more
europepmc   +1 more source

P5.22 CAROTID AND AORTIC STIFFNESS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Artery Research, 2011
A.I. Ershova, A.N. Meshkov, T.A. Rozhkova, A.N. Rogoza, T.V. Balakhonova, S.A. Boytsov   +5 more
doaj   +1 more source

Therapeutic apheresis in a pregnant woman with heterozygous familial hypercholesterolemia

Nefrología (English Edition)
Zoila Stany Albines Fiestas, María Victoria Rubio Rubio, José Antonio Gimeno Orna, Ana Belén Mañas Martínez, Virginia Arroyo Espallargas, Jordi Bosch Melguizo, Beatriz María Rojas Pérez-Ezquerra, Carmen Criado Mainar, Fernando Anaya-Fernández Lomana, Pablo Iñigo Gil   +9 more
doaj   +1 more source

Clinical Impact of Lipoprotein (a) and Cumulative Low-Density Lipoprotein Cholesterol Exposure on Coronary Artery Disease in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

J Atheroscler Thromb
Shishikura D, Harada-Shiba M, Michikura M, Fujioka S, Fujisaka T, Morita H, Kanzaki Y, Hoshiga M.   +7 more
europepmc   +1 more source

Biochemical and Anthropometric Outcomes in Paediatric Patients with Heterozygous Familial Hypercholesterolemia after COVID-19 Pandemic Lockdowns: An Exploratory Analysis. [PDF]

Nutrients
Peres M, Moreira-Rosário A, Padeira G, Gaspar Silva P, Correia C, Nunes A, Garcia E, Faria A, Teixeira D, Calhau C, Pereira-da-Silva L, Ferreira AC, Rocha JC.   +12 more
europepmc   +1 more source

Failure of lipid control by PCSK9 inhibitors in compound heterozygous familial hypercholesterolemia complicated with premature myocardial infarction: A case report. [PDF]

Clin Case Rep
Zhang Z, Yang R, Zhu J, Yang X, Luo H, Wang H, Luo X.   +6 more
europepmc   +1 more source

Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.

JAMA Pediatr
Santos RD, Wiegman A, Caprio S, Cariou B, Averna M, Poulouin Y, Scemama M, Manvelian G, Garon G, Daniels S.   +9 more
europepmc   +1 more source

† Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia

Journal of Clinical Lipidology
Andy Hsieh, Stephen Nicholls, Adam J Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Navar, Steven E. Nissen, Anne C. Goldberg, Liam R. Brunham, Erin Wuerdeman, Annie Neild, Douglas Kling, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Michael H. Davidson   +19 more
openaire   +1 more source